Table 1.

Mendelian randomization (MR)-Egger regression intercepts

Exposure	Outcome	Intercepts (95% CI)	P-val
TC	CKD	0.015 (−0.113, 0.066)	0.573
TG	CKD	−0.008 (− 0.047, 0.019)	0.553
LDL-C	CKD	−0.032 (− 0.105, 0.037)	0.461
HDL-C	CKD	−0.041 (− 0.150, 0.056)	0.492
ApoA1	CKD	0.009 (−0.088, 0.049)	0.682
ApoB	CKD	0.008 (−0.078, 0.036)	0.733

CKD Chronic kidney disease, TC Total cholesterol, TG Triglyceride, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, Apo Apolipoprotein, CI Confidence interval, MR Mendelian randomization; The significant result (P > 0.05) indicates that the y-intercept of the MR-Egger regression line is not significantly different from zero and thus no pleiotropy exists